Jim Simons
QNCX icon

Jim Simons’s Quince Therapeutics QNCX Stock Holding History

Jim Simons’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,691
Closed -$1.8M – 3601
2025
Q4 		$1.8M Buy
2,691
+348
+15% +$175K ﹤0.01% 1927
2025
Q3 		$764K Buy
2,343
+444
+23% +$148K ﹤0.01% 2618
2025
Q2 		$627K Sell
1,899
-601
-24% -$137K ﹤0.01% 2721
2025
Q1 		$665K Sell
2,500
-115
-4% -$35.1K ﹤0.01% 2621
2024
Q4 		$978K Buy
2,615
+2
+0.1% +$601 ﹤0.01% 2512
2024
Q3 		$406K Buy
2,613
+193
+8% +$27.7K ﹤0.01% 2875
2024
Q2 		$363K Sell
2,420
-181
-7% -$32.7K ﹤0.01% 2837
2024
Q1 		$551K Buy
2,601
+308
+13% +$76.5K ﹤0.01% 2819
2023
Q4 		$482K Buy
2,293
+668
+41% +$134K ﹤0.01% 2798
2023
Q3 		$364K Buy
1,625
+181
+13% +$47.3K ﹤0.01% 2851
2023
Q2 		$434K Buy
1,444
+295
+26% +$91.8K ﹤0.01% 2949
2023
Q1 		$358K Buy
1,149
+378
+49% +$74K ﹤0.01% 3044
2022
Q4 		$98K Sell
771
-900
-54% -$151K ﹤0.01% 3624
2022
Q3 		$445K Buy
1,671
+274
+20% +$104K ﹤0.01% 2996
2022
Q2 		$620K Buy
+1,397
New +$987K ﹤0.01% 3024
2020
Q4 		– Sell
-22
Closed -$220K – 3653
2020
Q3 		$220K Sell
22
-113
-84% -$1.03M ﹤0.01% 3076
2020
Q2 		$1.25M Buy
135
+110
+440% +$1.01M ﹤0.01% 2437
2020
Q1 		$226K Buy
+25
New +$247K ﹤0.01% 3071

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jim Simons's QNCX Position: Q1 2026 in Review

Jim Simons sold out of Quince Therapeutics (QNCX) in Q1 2026, closing a stake of 2,691 shares — an estimated $1.8M sold.

Jim Simons first reported a position in QNCX in Q1 2020 and held it in 18 quarters. The position peaked at $1.8M in Q4 2025. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • Jim Simons reported no remaining Quince Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 2,691 Quince Therapeutics shares in Q1 2026, an estimated $1.8M.
  • Jim Simons first reported a position in Quince Therapeutics in Q1 2020 and held it in 18 quarters.
  • Jim Simons's Quince Therapeutics position peaked at $1.8M in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.